Trial Profile
Usability testing of Minodoronate 50mg for secondary osteoporosis in prostatic caricnoma patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2017
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 04 Aug 2017 Status changed from not yet recruiting to discontinued.
- 07 May 2013 New trial record